Given that the frequency of a high-risk APOL1 genotype in the Black population is 13% (28), discovering a frequency of 77% to 90% in COVAN is profound and comparable to the 60% to 70% frequency reported in HIVAN (28–31). This evidence concerns the gene APOL1 and HIV-associated nephropathy.